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Abstract: Background: Influenza is a common preventable infectious disease associated with high 
mortality and morbidity. Vaccination is the most cost-effective measure to prevent influenza, yet 
the vaccine uptake is known to be low. No previous studies have assessed the rate of seasonal 
influenza vaccination use among the Lebanese population, nor examined the knowledge and 
attitudes towards the influenza vaccine. Methods: A cross-sectional survey was performed in 30 
pharmacies randomly selected across Lebanon. A 19-item questionnaire was used to record 
influenza vaccination status, knowledge and attitudes towards the influenza vaccine among the 
Lebanese general population. Results: The survey response rate was 93%. Among the 640 study 
participants, the overall 2014-2015 seasonal influenza vaccination rate was 27.6%. The majority of 
participants (72.4%) reported irregular uptake of the vaccine. Results of the multivariate analysis 
revealed that elderly people (OR = 2.25, CI = 1.08–4.71), with higher education (OR = 1.42,  
CI = 1.09–1.84), higher physical activity (OR significantly higher than 1 for all categories), and 
chronic respiratory disease (OR = 3.24, CI = 1.58–6.62) were more regularly vaccinated, while those 
who visit the doctor “only when needed” (OR = 0.55, CI = 0.34–0.88) and those who consume more than 
seven drinks/week (OR = 0.24, CI = 0.09–0.65) were less regularly vaccinated. When introducing 
knowledge and attitude variables to the model, “thinking that the vaccine was not needed” was the 
only correlate that demonstrated a significant inverse association with regular influenza vaccination 
(OR = 0.15; p = 0.017). Conclusions: Suboptimal vaccination rates exist among the Lebanese 
ambulatory adult population. Clear misinformation on the importance of regular influenza 
immunization is also highlighted. This evidence underscores a compelling need to raise public 
awareness regarding the efficacy of the influenza vaccine. 
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1. Introduction 
The influenza A and B viruses are human respiratory viruses that spread easily from person to 
person by droplets and aerosols [1]. Both viruses can affect any person in any age group and can 
cause seasonal influenza epidemics. Influenza A virus has the additional ability to generate 
worldwide pandemics. The Spanish flu (1918), Asian flu (1957), Hong Kong flu (1968) and the 2009 
global outbreak of H1N1 that evolved into a seasonal pattern in 2010, were associated with millions 
of deaths worldwide [1]. Each year, epidemics of seasonal influenza also result in about 3–5 million 
cases of severe illness and 250,000–500,000 deaths worldwide [1]. Moreover, seasonal influenza 
triggers lost workforce productivity and strain health services and is therefore considered a serious 
public health problem. Influenza vaccination is the most effective way to prevent infection and severe 
outcomes like hospitalization, mortality and morbidity [1–3]. For instance, vaccination in the elderly 
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was shown to decrease the risk of death from pneumococcal diseases and influenza-related 
complications by 50% and 80%, respectively [4].  
The latest recommendations from the World Health Organization (WHO) and the U.S. Center 
for Disease Control and Prevention (CDC) state that individuals aged 6 months and older are 
encouraged to get vaccinated against influenza in attempt to expand protection to more people. It is 
particularly important for individuals in high-risk groups to receive the annual influenza vaccination 
to prevent the risk of serious complications [5,6]. High risk groups are defined as individuals highly 
exposed to the influenza virus and or highly prone to develop severe disease or death post-exposure 
[5]. Pregnant women, pediatric and elderly patients, as well as patients with chronic heart or lung 
diseases, metabolic diseases and immunosuppressed states are classified as high risk [5,6]. Despite 
clear evidence on the benefits of the vaccine, adherence to the issued recommendations is not always 
successful. The CDC estimates annual influenza vaccination coverage for the United States by 
utilizing data from several nationally representative surveys. For the 2014/2015 seasonal influenza, it 
was revealed, as of early November, that more than half of Americans had not yet received the 
recommended influenza vaccination [7]. The European CDC published a report in 2014 that included 
the annual surveys conducted by the Vaccine European New Integrated Collaboration Effort 
(VENICE) project. The report concluded that only a handful of European Member States were 
achieving the influenza vaccination specific targets as per the recommendations [8].  
In Lebanon, influenza vaccine is paid for out-of-pocket since it is not part of the national 
vaccination program. Moreover, no national surveillance programs or awareness campaigns for 
influenza exist in the country. Data on the uptake of the influenza vaccine, knowledge and attitudes 
of the Lebanese population towards it, lack. A study by Romani et al. looked at the knowledge and 
beliefs of Lebanese family physicians regarding influenza vaccines and reported a clear deficiency in 
immunization awareness and practices [9]. In light of this, examining vaccination coverage rates as 
well as understanding the beliefs regarding influenza vaccine among the Lebanese community is  
an essential first step to postulating recommendations on vaccination practices. The objective of  
the proposed study is to evaluate the 2014–2015 seasonal influenza vaccination rate as well as assess 
the knowledge, attitudes and beliefs among a select Lebanese population towards the seasonal  
influenza vaccine.  
2. Methods 
A quantitative cross-sectional research design was developed to study the influenza vaccination 
rate among the Lebanese general population as well as the attitudes, and knowledge towards the 
influenza vaccine. The study was approved by the Lebanese American University’s Institutional 
Review Board. The purpose of the study was elucidated and participant consent was obtained prior 
to administering the surveys.  
2.1. Sample 
In Lebanon, pharmacies are considered easily accessible and constitute important frontline 
healthcare facilities for ambulatory patients, as the primary care services are relatively weak with 
only around 90 certified family physicians practicing in the country [9]. Therefore, the targeted 
population of ambulating Lebanese patients aged 18 years or above, was recruited from a random 
sample of community pharmacies across different regions of Lebanon from July to September 2015. 
To ensure a representative sample of adults, 30 pharmacies were randomly selected across the six 
Lebanese governorates: North of Lebanon, Mount Lebanon, Beirut, Beirut Suburb, South of Lebanon 
and Beqaa. In each pharmacy, around 20 subjects were interviewed face-to-face by pharmacy interns 
and were asked about their vaccination status. Since community pharmacies do not keep medical 
records, patients’ vaccination status, their knowledge and attitudes towards the influenza vaccine 
were self-reported through a questionnaire.  
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2.2. Instrument 
A 19-item questionnaire was developed based on available relevant literature. The instrument 
was used to record influenza vaccination status for 2014–2015 and assessed vaccination history. 
Yearly vaccine recipients were labeled as the “regular influenza vaccination” group and individuals 
who never or occasionally received the vaccine were the “irregular influenza vaccination” group. 
Knowledge and attitudes towards the vaccine among the Lebanese population were also collected. 
The instrument included six parts: socio-demographics (gender, age, region, educational level, 
financial situation, health insurance, smoking, alcohol consumption, and physical activity), medical 
history (frequency of medical visits, medical conditions, medicinal drugs and indications), 
vaccination status (date of last vaccine received in general and influenza vaccine in particular), 
general knowledge of seasonal influenza. Interviewed individuals were asked if they were able to 
recognize the influenza symptoms, its complications, its high risk groups and its vaccine. Awareness 
variables were assessed as binary outcomes. Willingness to get vaccinated, the perceived barriers and 
vaccine information sources (physician, pharmacist, family and friends, religious groups, media, 
governmental agencies) were also self-reported. To evaluate the clarity of the survey queries, a pilot 
study was carried out on 20 volunteers. Accordingly, minor modifications were made to question 
wording and layout based on feedback from the respondents and interviewers. 
2.3. Data Analysis 
Data was entered and analyzed using SPSS software, version 22.0 (IBM Corp, Armonk, NY, 
USA). We used descriptive statistics to assess socio-demographic characteristics, basic knowledge, as 
well as perceptions especially with regard to safety and usage, and practices. Multivariable logistic 
regression was used to assess associations of regular vaccine use among the interviewees as a 
dependent variable with independent variables, using adjusted odds ratios (OR). Socio-demographic 
factors, current health status, and participants’ attitudes towards the vaccine were the independent 
correlates and potential confounders. P values < 0.05 were considered statistically significant. 
3. Results 
3.1. Sample Description 
A total of 640 surveys were collected. The highest percentage (43%) of participants resided in 
Mount Lebanon (one of the major Lebanese governorates), 29.2% resided in Beirut and suburbs  
(the capital), while the rest resided in other Lebanese regions. Among the 640 study participants,  
299 (46.7%) were males, participants age ranged between 18 and 88 years and the median age was  
33 years. The sample distribution was judged to be representative of the Lebanese population in 
terms of age and gender, when compared to Lebanon official statistics (p > 0.05) [10]. Concerning the 
education level, 361 (56.4%) had a university degree, 181 (28.3%) reached high school, while 14.7% 
had low levels of education. The majority of participants (56.9%) were employed and 9.7% declared 
having no medical insurance. Our sample included patients belonging to high risk groups; 54 patients 
(8.4%) were aged 65 years or more, 75 (11.7%) had diabetes, 73 (11.4%) suffered from chronic heart 
disease, 40 (6.3%) had chronic respiratory disorder, 10 (1.6%) had cancer, 10 (1.6%) 9 (1.4%) chronic 
kidney disease and six (1%) were on chronic steroid therapy. 
3.2. Rates of Vaccine Uptake 
In this study, the overall 2014–2015 seasonal influenza vaccination rate was 27.6%. The majority 
of participants (72.4%) reported regular uptake of the vaccine. Among elderly patients aged more than 
65, 35.2% received regularly the vaccine. Except for respiratory disease, the majority of patients with 
chronic diseases did not report receiving immunization against influenza. For instance, 79.5% of 
patients with heart disease, 81.3% with diabetes, 81.8% with cancer and 83.3% of patients on chronic 
steroid therapy did not receive seasonal influenza vaccination. 
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Table 1. Socio-demographic characteristics and regular vaccination. 
Characteristic 
Regular Influenza 
Virus Vaccination 176 
(27.6%) 
Irregular Influenza Virus 
Vaccination N = 461 (72.4%) 
p-Value 
Gender    
Male 75 (25.1%) 224 (74.9%) 
0.177 
Female 101 (29.9%) 237 (70.1%) 
Age quartiles    
<24 years 50 (30.7%) 113 (69.3%) 
0.029 
24–33 years 51 (32.3%) 107 (67.7%) 
34–51 years 40 (23.8%) 128 (76.2%) 
52–64 years 16 (16.8%) 79 (83.2%) 
65 and more 19 (35.2%) 35 (64.8%) 
Area of residency    
North Lebanon 20 (27.8%) 52 (72.2%) 
0.366 
Mount Lebanon 85 (30.9%) 190 (69.1%) 
Beirut 45 (24.1%) 142 (75.9%) 
Beirut suburbs 11 (18.6%) 48 (81.4%) 
South Lebanon 8 (32.0%) 17 (68.0%) 
Bekaa 2 (22.2%) 7 (77.8%) 
Education level    
No education 4 (11.1%) 32 (88.9%) 
0.004 
Below high school 17 (29.3%) 41 (70.7%) 
High school 38 (21.0%) 143 (79.0%) 
University degree 117 (32.4%) 244 (67.6%) 
Employment    
No 69 (25.4%) 203 (74.6%) 
0.294 
Yes 106 (29.1%) 258 (70.9%) 
Health Insurance    
None 12 (19.4%) 50 (80.6%) 
0.008 Public insurance 55 (22.4%) 190 (77.6%) 
Private insurance 107 (32.7%) 220 (67.3%) 
Financial situation    
Comfortable 106 (32.7%) 218 (67.3%) 
0.007 Manageable 60 (23.0%) 201 (77.0%) 
Difficult 8 (16.7%) 40 (83.3%) 
3.3. Association of Participants Socio-Demographic, Lifestyle Characteristics and Seasonal Influenza 
Vaccination 
The correlations between socio-demographic and lifestyle characteristics and regular 
vaccination are summarized in Tables 1 and 2, respectively. Education levels, employment status as 
well as perceived financial situation affected vaccination uptake. There was a clear and significantly 
low level of vaccination among those with a low level of education compared to more educated 
individuals (p = 0.004). Additionally, participants with no health insurance and with public insurance 
had a lower level of vaccination in comparison with private insurance (p = 0.008); moreover, people 
with perceived “comfortable” financial situation had higher level of vaccination (p = 0.007). Gender 
and area of residency did not affect vaccination rates, while age affected it. A lower rate of vaccination 
was observed with increased age, except for patients aged 65 and above who showed higher rates of 
regular vaccination vs. younger patients (p = 0.029). Regarding social history, the highest rates of 
influenza vaccines were found among non-smokers and heavy smokers (p = 0.03). Heavy alcohol 
consumers presented the lowest rate of vaccination (p = 0.013), as well as participants reporting to 
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never perform any physical activity (p = 0.001). Moreover, subjects who reported medical visits “only 
when needed” as opposed to routine medical visits had the lowest rate of influenza vaccination  
(p = 0.001)  
Table 2. Lifestyle characteristics and influenza vaccination. 
Characteristic 
Regular Influenza Virus 
Vaccination 176 (27.6%) 
 Irregular Influenza Virus 
Vaccination N = 461 (72.4%) 
p-value 
Cigarette smoking    
Never 115 (31.5%) 250 (68.5%) 
0.030 
<15 cigarettes/day 40 (21.6%) 145 (78.4%) 
16–24 cigarettes/day 13 (19.7%) 53 (80.3%) 
25 cigarettes/day or more 7 (36.8%) 12 (63.2%) 
Alcohol drinking    
Never 86 (27.5%) 227 (72.5%) 
0.013 1–7 drinks/week 85 (30.6%) 193 (69.4%) 
More than 7 drinks/week 5 (10.2%) 44 (89.9.2%) 
Exercise    
Never 50 (19.3%) 209 (80.7%) 
0.001 
Less than twice/week 53 (29.9%) 124 (70.1%) 
2–3 times/week 50 (35.7%) 90 (64.3%) 
More than 3 times/week 23 (37.7%) 38 (62.3%) 
Medical visit    
Routinely 46 (33.8%) 90 (66.2%) 
0.001 Once/year 37 (38.5%) 59 (61.5%) 
When needed 91 (22.8%) 309 (77.3%) 
3.4. Association of Chronic Disease Conditions and Influenza Vaccination 
When observing the vaccination rates among patients with specific comorbidities, there was no 
significant association established between chronic disease conditions and influenza vaccination, 
except for chronic respiratory diseases. Patients with respiratory diseases were found to have almost  
a double rate of seasonal influenza vaccination when compared to patients without this comorbidity 
(50% vs. 26.3%, p = 0.001) as shown in Table 3.  
Table 3. Chronic disease conditions and influenza vaccination. 
Characteristic 
Regular Influenza Virus 
Vaccination 176 (27.6%) 
 Irregular Influenza Virus 
Vaccination N = 461 (72.4%) 
p-Value 
Heart disease   
0.144 Yes 15 (20.5%) 58 (79.5%) 
No 161 (28.7%) 400 (71.3%) 
Neurological disease   
0.735 * Yes 2 (20.0%) 8 (80.0%) 
No 173 (27.8%) 450 (72.2%) 
Diabetes mellitus   
0.061 Yes 14 (18.7%) 61 (81.3%) 
No 162 (29.0%) 397 (71.0%) 
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Table 3. Cont. 
Characteristic 
Regular Influenza Virus 
Vaccination 176 (27.6%) 
 Irregular Influenza Virus 
Vaccination N = 461 (72.4%) 
p-Value 
Liver disease   
1.000 * Yes 1 (33.3%) 2 (66.7%) 
No 175 (27.7%) 456 (72.3%) 
Kidney disease   
0.069 * Yes 0 9 (100.0%) 
No 176 (28.2%) 448 (71.8%) 
Cancer   
0.736 * Yes 2 (18.2%) 9 (81.8%) 
No 173 (27.9%) 447 (72.1%) 
Respiratory disease   
0.001 Yes 20 (50.0%) 20 (50.0%) 
No 156 (26.3%) 438 (73.7%) 
Disease requiring 
steroids treatment 
  
1.000 * 
Yes 1 (16.7%) 5 (83.3%) 
No 174 (27.8%) 452 (72.2%) 
* Fisher exact test used. 
3.5. Knowledge, Attitude and Practice of Influenza Vaccination 
In Table 4, we present associations between knowledge, attitude and practice of influenza 
vaccination. A better knowledge about the influenza disease (symptoms, severity and risk) and about 
the vaccine (availability, efficacy and safety) is associated with higher regular vaccination rate  
(p < 0.001). When assessing the vaccine source of information, we found that the pharmacist  
(p = 0.001) and the physician (p = 0.024) followed by family members (p = 0.025) are associated with 
higher regular vaccination rates. The media (p = 0.158) and the government (p = 1) were not shown to 
have any role in disseminating information on the influenza vaccine. 
Table 4. Knowledge, attitude and practice of influenza vaccination. 
Characteristic 
Regular Influenza 
Virus Vaccination 176 
(27.6%) 
 p-Value 
Aware of influenza symptoms   
<0.001 Yes 168 (30.8%)  
No  6 (9.1%)  
Aware of influenza severity   
<0.001 Yes 149 (34.3%)  
No 19 (12.8%)  
Aware of influenza risk   
<0.001 
Yes 144 (37.8%) 
237 
(62.2%) 
No  20 (10.8%) 
166 
(89.2%) 
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Table 4. Cont. 
Characteristic 
Regular Influenza 
Virus Vaccination 176 
(27.6%) 
 p-Value 
Aware of vaccination 
needs/availability 
  
0.001 
Yes 170 (29.8%) 
401 
(70.2%) 
No 5 (11.9%) 37 (88.1%) 
Thinks that vaccination is effective   
<0.001 
Yes 145 (43.2%) 
191 
(56.8%) 
No 11 (10.3%) 96 (89.7%) 
Does not know 18 (9.5%) 
171 
(90.5%) 
The vaccine should be taken at a 
specific time 
  
<0.001 
Yes 146 (42.0%) 
202 
(58.0%) 
No 11 (13.6%) 70 (86.4%) 
Does not know 16 (7.8%) 
188 
(92.2%) 
Thinks the vaccine is safe   
<0.001 
Yes 155 (38.8%) 
244 
(61.2%) 
No 10 (16.9%) 49 (93.1%) 
Does not know 9 ( 5.1%) 
166 
(94.9%) 
Thinks the vaccine is for children only   
<0.001 
Yes 16 (23.9%) 51 (76.1%) 
No 144 (33.1%) 
291 
(66.9%) 
Does not know 15 (11.3%) 
118 
(88.7%) 
Has a fear of needles   
0.720 
Yes 3 (4.8%) 59 (95.2%) 
No 8 (3.9%) 
198 
(96.1%) 
Thinks the vaccine is expensive   
0.371 
Yes 0 32 (100%) 
No 11 (4.7%) 
223 
(95.3%) 
Thinks there is no need for the vaccine   
0.127 
Yes 4 (2.7%) 
145 
(97.3%) 
No 8 (6.5%) 
115 
(93.5%) 
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Table 4. Cont. 
Characteristic 
Regular Influenza 
Virus Vaccination 176 
(27.6%) 
 p-Value 
Source of information is the physician 117 (31.0%) 
260 
(69.0%) 
0.024 
Source of information is the 
pharmacist 
109 (33.0%) 
221 
(67.0%) 
0.001 
Source of information is the 
parents/family 
40 (21.5%) 
146 
(78.5%) 
0.025 
Source of information is the media 23 (21.9%) 82 (78.1%) 0.158 
Source of information is the 
government 
2 (28.6%) 5 (71.4%) 1.000 
3.6. Multivariate Analysis and the Correlates of Regular Influenza Vaccination 
The results of the multivariate analysis can be found in Table 5. We conducted a multivariate 
analysis and found in model 1, that elderly people (OR = 2.25, CI = 1.08–4.71), with higher education 
(OR = 1.42, CI = 1.09–1.84), higher physical activity (OR significantly above 1), and chronic respiratory 
disease (OR = 3.24, CI = 1.58–6.62) are more regularly vaccinated, while those who visit the doctor 
only when needed (OR = 0.55, CI = 0.34–0.88) and those who consume more than 7 drinks/week  
(OR = 0.24, CI = 0.09–0.65) were less regularly vaccinated. Other factors, such as gender, residential 
area, alcohol consumption, financial situation, having health insurance had no influence on the 
probability of vaccine uptake. 
Table 5. Multivariate analysis: correlates of regular influenza vaccination. 
Model Correlates of Regular Influenza Vaccination OR 95% CI p-Value 
1 
Age > 65 years 2.25 1.08–4.71 0.031 
Higher level of education 1.42 1.09–1.84 0.008 
Alcohol consumption (>7 drinks/week vs. 
never) 
0.24 0.09–0.65 0.005 
Physical activity level   0.003 
Less than twice/week vs. never 1.85 1.13–3.04 0.015 
2–3 times/week vs. never 2.46 1.48–4.11 0.001 
More than 3 times/week vs. never 2.31 1.17–4.56 0.016 
Medical visits   0.004 
Once/year vs. routinely 1.15 0.63–2.09 0.650 
When needed vs. routinely 0.55 0.34–0.88 0.013 
Having a chronic respiratory disease 3.24 1.58–6.62 0.001 
2 
Medical visits   0.035 
 Once/year vs. routinely 4.43 0.49–40.11 0.186 
 When needed vs. routinely 0.30 0.06–1.61 0.162 
Thinking the vaccine is not needed 0.15 0.03–0.71 0.017 
Model 1: In the stepwise descendent logistic regression to predict regular influenza vaccination, variables 
entered on step 1 were: gender, age, education, health insurance, financial situation, smoking, alcohol 
consumption, exercise, medical visits, heart disease, diabetes mellitus, kidney disease and respiratory disease. 
Nagelkerke R-Square = 0.143; Hosmer-Lemeshow: p = 0.417. Model 2: In addition to variables previously retained 
in model 1, knowledge and attitude variables were introduced. Nagelkerke R-square = 0.406; Hosmer-
Lemeshow: p = 0.909.  
When introducing knowledge and attitude variables to the previous model, the results showed 
“thinking that the vaccine was not needed” was the only correlate that demonstrated a significant 
inverse association with regular influenza vaccination (OR = 0.15; p = 0.017), while “visiting the doctor 
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only when needed” showed an inverse but not significant association; all other variables were 
removed from the model because they were not significantly associated with regular influenza 
vaccination.  
4. Discussion  
4.1. Rates of Influenza Vaccination 
The results from our study revealed an overall vaccination rate of 27.6%. This coverage might 
be an overestimation of the actual prevalence of vaccination in the Lebanese adult population since 
our subjects were interviewed in community pharmacies. Low vaccination rates are a worldwide 
public health problem. Continuous efforts to design and implement quality improvement 
interventions for increasing the rates of influenza vaccinations are being examined across nations. 
From patient reminder and recall systems to posters in physician offices tracking vaccination 
progress, no single intervention was able to solve this challenge [11–13].  
Indeed, the National Internet Flu Survey sponsored by the CDC estimated a vaccination rate of 
the U.S adult population equivalent to 39.7% for the 2014–2015 influenza season [7]. European 
countries are also struggling to achieve the influenza vaccination specific targets as per the 
recommendations [8]. 
Low vaccination coverages become particularly concerning in high risk groups. In our study, 
elderly patients and/or patients with chronic diseases (heart disease, cancer, diabetes) or 
immunosuppressed statuses were also found to have suboptimal immunization rates ranging from 
18.2% to 35%. For respiratory diseases, rates were improved to 50%, however still remained 
suboptimal. The European CDC recommended that influenza vaccination rates for winter 2014–2015 
reach a target of 75% in older adults as well as in individuals with chronic conditions [8].  
4.2. Factors Associated with Seasonal Influenza Vaccine Uptake 
Future vaccination efforts have to particularly target subjects with low vaccine uptake. It is 
therefore important to recognize individuals who abstain from or oppose to receive the vaccine. Both 
our bivariate and multivariate analysis revealed that individuals with higher levels of education with 
active, non-sedentary lifestyles, non-smokers or heavy smokers, in addition to older adults (above  
65 years) were positive predictors of vaccine uptake. Physically active, non-smokers, more educated 
individuals tend to perceive health as a priority and are able to make healthier life choices by 
adhering to recommendations [14]. 
These findings echo the results of many studies which found a strong association between low 
socio-economic status (SES) individuals and low vaccination rates. Indeed, Winston et al. documented 
a negative association between low SES subjects and seasonal influenza vaccination [15]. 
Additionally, Baudier and Leon observed much lower rates of up-to-date immunization profiles 
among the unemployed and those with lower educational levels [16]. The explanation to such 
findings can be a result of misinformation and ignorance in the low SES group [17,18]. Indeed, when 
examining the knowledge and attitudes of this group of participants, a clear lack of awareness on 
influenza disease symptoms, risks, vaccine availability, efficacy and safety was observed.  
An important additional contributing factor is the accessibility to vaccination. In fact, the 
majority of patients with a difficult financial situation stated that they thought the vaccine was 
expensive: 53.6%, versus 10.8% in case of manageable financial situation, and 3.4% for those with 
comfortable financial situation (p < 0.001; results not shown). This factor was however overridden in 
the multivariable analysis by the perceived need of the vaccine.  
Among patients with chronic conditions, only those with respiratory disorders were being 
immunized against influenza virus with statistical significance (p < 0.01), when compared to other 
patients suffering from other chronic diseases. This finding highlights the need to increase 
immunization efforts in the chronic disease population since influenza vaccine was proven to reduce 
hospitalization, morbidity and mortality in the elderly as well as the chronically ill patients [1–3].  
For instance, vaccination in elderly was shown to decrease the risk of death from pneumococcal 
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diseases and influenza-related complications by 50% and 80% respectively [4]. Furthermore, routine 
vaccination for diabetic children and adults was proven to reduce diabetes-related hospital admission 
by around 79% [19]. 
4.3. Knowledge and Attitude towards Vaccination 
Our results revealed that “thinking that the vaccine was not needed” was the only correlate 
significantly associated with abstinence from regular vaccination. Clear misinformation exists among 
the Lebanese community towards the influenza vaccine. The population represented in our study 
falsely believed that regular influenza immunization is not essential. This evidence underscores  
a compelling need to raise public awareness regarding the importance of regular influenza 
vaccination. 
4.4. Source of Vaccine Information 
For all our studied participants, the main sources of information regarding vaccination were the 
physician and the pharmacists. Moreover, individuals who regularly followed-up with their 
physicians benefited from the vaccination opportunities offered during routine health care visits. The 
role of healthcare providers in promoting and reinforcing adherence to vaccination is clearly 
highlighted by this observation. Other studies also suggested that healthcare providers’ 
recommendations for regular vaccination were positive predictors to compliance [20,21]. Therefore, 
physicians, pharmacists, among other health care providers are invited to demonstrate knowledge of 
current immunization practices and recommendations. Remarkably, the role of the government, as a 
source of information, was revealed absent in the Lebanese community. The Lebanese ministries of 
health and public health should be prompted to educate the public on the importance of vaccination 
as well as to address the barriers to vaccine accessibility. For instance, adopting the influenza vaccine 
under the national vaccination program, organizing awareness campaigns and allocating national 
funds to cover it are essential steps. 
4.5. Limitations 
Our study does have potential limitations. Like all pharmacy-based patient surveys, a selection 
bias might have occurred. Extrapolation of data may not be accurate in institutionalized or 
homebound subjects or those individuals less likely to visit the pharmacy. Additionally, under-or 
inaccurate reporting might have occurred since participants were asked to self-report their 
vaccination statuses and awareness variables were measured using binary outcomes. The timing of 
the study might have influenced the results since participants might be more aware of influenza 
vaccination around fall and winter. Despite the mentioned limitations, the major strength of our 
study resides in the fact that it was the first one to include a large number of individuals surveyed 
from the general population across the country and report on their seasonal vaccination attitudes and 
practices. 
5. Conclusions 
The present study is the first to report the rates of vaccination among a selected Lebanese 
ambulatory adult population. Results showed that seasonal influenza immunization rates were low 
particularly among the low SES individuals. Patients with chronic diseases, other than respiratory,  
are sub optimally vaccinated. The major barrier to abstinence from vaccination is that the vaccine was 
viewed as not needed. The current results therefore emphasize the compelling need for spreading 
public awareness in Lebanon regarding the efficacy and benefits of seasonal influenza vaccination. 
Routine consultation with HCP is essential to enhance immunization opportunities. Furthermore,  
a collaborative effort of governmental bodies and health-care providers is recommended to educate, 
regulate and improve immunization practices through public and professional awareness 
campaigns. 
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